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Biopharmaceuticals represent one of the crucial areas in the pharmacy and are widely used to 
treat several diseases. Protein molecules are typically unstable in aqueous media, thus 
lyophilisation is the method of choice to transform such formulations into solid state. Initially 
biopharmaceuticals were intended for intravenous administration, whereas current trends 
are oriented in development of protein formulations for subcutaneous administration, which 
is associated with many challenges [1]. 
The main aim was to evaluate the effect of bovine serum albumin (BSA) concentration on 
formulation viscosity, further on related to critical quality attributes of lyophilized 
formulations, such as reconstitution time and visual appearance.  
Formulations with five different BSA concentrations (5, 20, 50, 70 and 100 mg/mL) in 
phosphate buffer and sucrose or sucrose/mannitol as excipients were subjected to 
lyophilisation. Lyophilised products were evaluated for visual appearance, reconstitution time 
and particle size by dynamic light scattering. In addition, viscosity and thermal characteristics 
of pre-lyophilized solutions were determined. 
Obtained results revealed that by increasing BSA concentration the reconstitution time was 
prolonged, while cake appearance was improved. Independent of formulation composition, 
the particle diameter was below 9 nm indicating absence of aggregates. Furthermore, an 
increase of viscosity with increasing BSA concentration was demonstrated. 
The study indicates that BSA concentration along with excipient added have a decisive impact 
on lyophilized formulation characteristics, namely prolonged reconstitution time and 
increased viscosity both represent a main challenge in development of highly concentrated 
protein formulations. 
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